BioScrip Acquires CarePoint for $223 Million


Jun 18, 2013

Bloomberg Businessweek

BioScrip Inc. plans to expand its drug infusion business with a new acquisition of CarePoint for $223 million. BioScrip, Inc. provides medication infusion services such as IVs and administers prescription drug benefits. CarePoint Partners provides infustion services at walk-in locations and patients'homes, minizing the need for patients to go to hospitals for treatment. BioScrip expects annual revenue of $160 million from CarePoint. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments